Medy-Tox Inc. (KOSDAQ: 086900)
South Korea
· Delayed Price · Currency is KRW
126,200
+300 (0.24%)
Nov 15, 2024, 9:00 AM KST
Medy-Tox Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 14, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Market Capitalization | 849,490 | 1,621,720 | 806,183 | 876,202 | 1,017,738 | 1,677,322 | Upgrade
|
Market Cap Growth | -34.80% | 101.16% | -7.99% | -13.91% | -39.32% | -46.65% | Upgrade
|
Enterprise Value | 915,276 | 1,671,460 | 885,688 | 929,154 | 1,099,207 | 1,755,736 | Upgrade
|
Last Close Price | 126200.00 | 239654.31 | 126728.56 | 134489.78 | 154789.20 | 252230.25 | Upgrade
|
PE Ratio | 188.11 | 182.80 | 23.09 | 9.26 | - | 62.27 | Upgrade
|
Forward PE | 19.34 | 31.75 | 27.88 | 23.25 | 107.65 | 29.43 | Upgrade
|
PS Ratio | 3.51 | 7.33 | 4.13 | 4.74 | 7.23 | 8.15 | Upgrade
|
PB Ratio | 1.80 | 3.42 | 1.86 | 2.17 | 4.16 | 6.39 | Upgrade
|
P/TBV Ratio | 2.18 | 3.49 | 1.90 | 2.23 | 4.48 | 6.88 | Upgrade
|
P/FCF Ratio | 292.82 | 276.65 | 49.45 | 357.35 | - | 132.26 | Upgrade
|
P/OCF Ratio | 96.58 | 119.94 | 30.77 | 43.89 | 36.44 | 49.77 | Upgrade
|
PEG Ratio | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 | Upgrade
|
EV/Sales Ratio | 3.72 | 7.56 | 4.54 | 5.03 | 7.81 | 8.53 | Upgrade
|
EV/EBITDA Ratio | 23.51 | 51.12 | 14.34 | 18.08 | - | 40.06 | Upgrade
|
EV/EBIT Ratio | 44.32 | 96.49 | 18.98 | 28.04 | - | 68.35 | Upgrade
|
EV/FCF Ratio | 315.50 | 285.14 | 54.32 | 378.95 | - | 138.44 | Upgrade
|
Debt / Equity Ratio | 0.19 | 0.17 | 0.28 | 0.33 | 0.60 | 0.39 | Upgrade
|
Debt / EBITDA Ratio | 2.41 | 2.53 | 1.96 | 2.59 | - | 2.34 | Upgrade
|
Debt / FCF Ratio | 31.32 | 14.13 | 7.41 | 54.21 | - | 8.08 | Upgrade
|
Asset Turnover | 0.40 | 0.37 | 0.33 | 0.35 | 0.32 | 0.50 | Upgrade
|
Inventory Turnover | 1.53 | 1.56 | 1.61 | 2.25 | 2.00 | 2.76 | Upgrade
|
Quick Ratio | 0.74 | 0.79 | 0.57 | 1.14 | 0.81 | 0.60 | Upgrade
|
Current Ratio | 1.28 | 1.31 | 1.00 | 1.49 | 1.18 | 0.88 | Upgrade
|
Return on Equity (ROE) | 1.14% | 2.13% | 8.74% | 28.77% | -11.84% | 9.83% | Upgrade
|
Return on Assets (ROA) | 1.99% | 1.79% | 4.97% | 3.96% | -5.21% | 3.93% | Upgrade
|
Return on Capital (ROIC) | 2.12% | 1.95% | 5.35% | 4.46% | -6.12% | 4.55% | Upgrade
|
Earnings Yield | 0.53% | 0.60% | 4.59% | 10.75% | -2.91% | 1.56% | Upgrade
|
FCF Yield | 0.34% | 0.36% | 2.02% | 0.28% | -1.30% | 0.76% | Upgrade
|
Dividend Yield | 0.87% | 0.46% | - | - | - | - | Upgrade
|
Payout Ratio | 151.21% | 86.34% | 21.74% | - | - | 16.52% | Upgrade
|
Buyback Yield / Dilution | 49.34% | -2.02% | -2.28% | -0.04% | 0.82% | -2.75% | Upgrade
|
Total Shareholder Return | 50.22% | -1.56% | -2.28% | -0.04% | 0.82% | -2.75% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.